Showing results (31-40 of 240) with videos related to
Sort By:
Pageof 24
Journal of Neuropathology and Experimental Neurology|November 7, 2007
Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodiesKaty A Chalmers, Seth LoveClinical Science (London, England : 1979)|July 2, 2017
Small vessel disease, neurovascular regulation and cognitive impairment: post-mortem studies reveal a complex relationship, still poorly understoodSeth Love, J Scott MinersJournal of Neuropathology and Experimental Neurology|February 7, 2007
Neurofibrillary tangles may interfere with Smad 2/3 signaling in neuronsKaty A Chalmers, Seth LoveJournal of Alzheimer'S Disease : JAD|July 22, 2017
Effect of APOE Genotype on Synaptic Proteins in Earlier Adult LifeLindsey I Sinclair, Seth LoveJournal of Neurochemistry|February 8, 2017
Endothelin-converting enzymes degrade α-synuclein and are reduced in dementia with Lewy bodiesJames Scott Miners, Seth LoveBrain Pathology (Zurich, Switzerland)|June 22, 2016
Cerebral Hypoperfusion and the Energy Deficit in Alzheimer's DiseaseSeth Love, J Scott MinersActa Neuropathologica|December 30, 2015
Cerebrovascular disease in ageing and Alzheimer's diseaseSeth Love, J Scott MinersMultiple Sclerosis (Houndmills, Basingstoke, England)|June 15, 2010
Characterization of in vitro expanded bone marrow-derived mesenchymal stem cells from patients with multiple sclerosisElizabeth Mallam, Kevin Kemp, Alastair Wilkins, et al.Journal of Neurology|January 13, 2005
Plasma exchange in episodes of severe inflammatory demyelination of the central nervous system. A report of six casesLuke Bennetto, April Totham, Pat Healy, et al.Journal of Neuroinflammation|April 7, 2012
The PPAR-γ agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal functionElizabeth Gray, Mark Ginty, Kevin Kemp, et al.Pageof 24